Cosmos Health announced that its proprietary antiseptic solution C-Sept PRO has gained strong traction across leading public and private hospital groups in Greece, with annualized sales poised to exceed $1.3 million at a gross margin of approximately 72%. Average monthly sales surpassed $93,000 over the past six months and accelerated to more than $108,000 per month over the past three months, generating roughly $0.9 million in annualized gross profit. The product is a professional-grade antiseptic combining chlorhexidine gluconate and isopropyl alcohol, used routinely for surgical and daily hand disinfection, pre-operative skin preparation, and catheterization. The company views its hospital business as a new high-margin revenue stream with recurring demand and intends to expand into additional European markets using its GMP-certified manufacturing platform and distribution network.
Cosmos Health Inc.C-Sept PRO gaining traction with hospital groups, driving annualized sales >$1.3M at 72% gross margin.